{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct03115112",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct03115112",
  "name": "Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects",
  "aliases": [
    "NCT03115112"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 386 participants.",
  "summary_technical": "Registry record NCT03115112. Randomized; quadruple masking; primary purpose treatment. Start 2017-10-12 (actual); primary completion 2018-10-31 (actual). Results posted on 2021-06-04.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT03115112",
      "normalized_value": "NCT03115112",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "diabetes-and-metabolic-disease"
      ],
      "system": [
        "metabolism"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; quadruple masking; primary purpose treatment",
    "drug_phase": "3",
    "registry_statuses": [
      {
        "status": "COMPLETED",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      }
    ],
    "start_date": {
      "date": "2017-10-12",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
    },
    "primary_completion_date": {
      "date": "2018-10-31",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
    },
    "completion_date": {
      "date": "2018-10-31",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
    },
    "results_first_posted": {
      "date": "2021-06-04",
      "type": null,
      "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
    },
    "countries": [
      {
        "code": "US",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      },
      {
        "code": "CZ",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      },
      {
        "code": "HU",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      },
      {
        "code": "JP",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      },
      {
        "code": "PL",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      },
      {
        "code": "ES",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 386,
        "basis": "enrolled",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct03115112-2021-06-22"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Condition",
        "value": "Type 2 Diabetes Mellitus",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Bexagliflozin",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Sitagliptin",
        "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Placebo for sitagliptin",
        "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Placebo for bexagliflozin",
        "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
      },
      {
        "label": "Lead sponsor",
        "value": "Theracos",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      }
    ]
  },
  "content_digest": "e2e8b4711a8980704d27f2e6b28e7421a3ff7cfd5b6095279857954fd58b9490",
  "review": {
    "content_digest": "e2e8b4711a8980704d27f2e6b28e7421a3ff7cfd5b6095279857954fd58b9490",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:type-2-diabetes",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03115112-2021-06-22",
          "locator": "derivedSection.conditionBrowseModule.meshes[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "sponsored_by",
        "label": "Registry lists this organization as the lead sponsor",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:org-theracos",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03115112-2021-06-22",
          "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
        },
        "primary": false,
        "role": "lead",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct03115112/",
  "context_path": "api/v1/context/cardio--ct-nct03115112.md"
}
